Don't Be Biased!

Moderator(s)

• 

  Marie Linder, PhD (she/her/hers)

  Senior statistician
  Centre for Pharmacoepidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden
  Stockholm, Sweden
• 

  Jeremy Rassen, ScD, FISPE

  Co-founder and President
  Aetion
  Sharon, United States

Presentations:

• 5:15 PM – 5:30 PM CEST

  Immortal bias from different lengths of grace period in a clone-censor-weight design: a simulation study.
  

  Presenting Author: Michael Chun-Yuan Cheng, MA (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan

  Co-Author: Albert Tzu-Ming Chuang, PharmD – National Cheng Kung University

  Co-Author: Edward Chia-Cheng Lai, PhD (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan
• 5:30 PM – 5:45 PM CEST

  Using simulations to evaluate characteristics of negative control outcomes and their impact on bias detection
  

  Presenting Author: Zafar Zafari, MSc, PhD – University of Maryland School of Pharmacy

  Co-Author: Susan dosReis, PhD – University of Maryland School of Pharmacy

  Co-Author: Jeong-eun Park, AB, MPH, RPh – University of Maryland School of Pharmacy

  Co-Author: Wei Hua, MSc, MHS, MD, PhD – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, USA

  Co-Author: Yong Ma, Ph.D – Office of Biostatistics, Office of Translational Sciences, Center of Drug Evaluation and Research, FDA

  Co-Author: Fang Tian – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD
• 5:45 PM – 6:00 PM CEST

  Using QBA in the Selection of Computable Operational Definitions to Minimize Misclassification & Underpower in RWE Studies
  

  Presenting Author: Aaron Kamauu, MD MS MPH – Navidence

  Co-Author: Christen M. Gray – BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK

  Co-Author: Carla A. Talarico, PhD – AstraZeneca

  Co-Author: Craig Parker, MD MS – Navidence

  Co-Author: Jared Kamauu – Navidence

  Co-Author: Amanda Shields – Navidence

  Co-Author: Sylvia Taylor, PhD, MPH, MBA – Medical Evidence, Vaccines and Immune Therapies Unit, AstraZeneca

  Co-Author: Sudhir Venkatesan, PhD, MPH – BPM Evidence Statistics, BioPharmaceuticals Medical, AstraZeneca
• 6:00 PM – 6:15 PM CEST

  Parameterization of beta distributions for bias parameters of binary exposure misclassification in probabilistic bias analysis
  

  Presenting Author: Qi Zhang, MSPH (she/her/hers) – Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA

  Co-Author: Richard F. MacLehose – Division of Epidemiology & Community Health, School of Public Health, University of Minnesota, Minneapolis, MN

  Co-Author: Lindsay J. Collin – Department of Population Health Sciences, Huntsman Cancer Institute University of Utah, Salt Lake City, UT

  Co-Author: Thomas P. Ahern – Departments of Surgery of Biochemistry, Larner College of Medicine, University of Vermont, Burlington, VT

  Co-Author: Timothy L. Lash, DSc – Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA
• 6:15 PM – 6:30 PM CEST

  Breaking Bias Barriers: Quantitative Bias Analysis for Rigorous Real-World Evidence
  

  Presenting Author: Grace Hsu, MSc – Cytel
• 6:30 PM – 6:45 PM CEST

  Adjusting number of cases, risk, risk difference and risk ratio estimated through an algorithm with unknown sensitivity: a contribution from the ConcePTION project
  

  Presenting Author: Giorgio Limoncella – University of Florence, Florence, Italy

  Co-Author: Leonardo Grilli, PhD – University of Florence

  Co-Author: Emanuela Dreassi – University of Florence

  Co-Author: Carla Rampichini, PhD – University of Florence

  Co-Author: Robert W. Platt, PhD (he/him/his) – McGill University

  Co-Author: Rosa Gini, PhD (she/her/hers) – ARS Toscana, Florence, Italy